Literature DB >> 16631238

Patterns and frequency of recurrences of squamous cell carcinoma of the vulva.

Jorien M Woolderink1, Geertruida H de Bock, Joanne A de Hullu, Margaret J Davy, Ate G J van der Zee, Marian J E Mourits.   

Abstract

OBJECTIVE: To analyze patterns and frequency of recurrences of squamous cell carcinoma (SCC) of the vulva after wide local excision (WLE) and superficial inguinal lymphadenectomy with separate incisions and to identify prognostic factors for the development of recurrences.
METHODS: Between January 1985 and December 1999, all 125 consecutive patients with primary SCC of the vulva, treated with WLE and superficial inguinal lymphadenectomy, were retrospectively analyzed. Recurrences were registered by localization as: local, skin bridge, groin or distant.
RESULTS: A local recurrence was diagnosed in 29 (23%) patients, 11 (9%) developed a groin and 4 (3%) a distant recurrence. No skin bridge recurrences were identified. The 5 years local relapse-free survival was 70%. After a first local recurrence, 72% of these patients developed a second local recurrence. Adjusted for other predictors, older age (>74 years) is an independent risk factor for local recurrences (HR: 2.38; 95%-C.I.: 1.08-5.23) and stage III/IV cancer for developing groin/distant recurrences (HR: 3.03; 95%-C.I.: 1.0-9.18).
CONCLUSION: WLE and superficial inguinal lymphadenectomy with separate incisions result in a high groin recurrence rate in this study; superficial lymphadenectomy should be replaced by deep inguinofemoral lymphadenectomy. After a local recurrence, 72% of the patients developed a second local recurrence. These patients are at high risk and need a close follow-up.

Entities:  

Mesh:

Year:  2006        PMID: 16631238     DOI: 10.1016/j.ygyno.2006.03.010

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  8 in total

1.  Diagnosis, Therapy and Follow-up Care of Vulvar Cancer and its Precursors. Guideline of the DGGG and DKG (S2k-Level, AWMF Registry Number 015/059, November 2015.

Authors:  H G Schnürch; S Ackermann; C D Alt; J Barinoff; C Böing; C Dannecker; F Gieseking; A Günthert; P Hantschmann; L C Horn; R Kürzl; P Mallmann; S Marnitz; G Mehlhorn; C C Hack; M C Koch; U Torsten; W Weikel; L Wölber; M Hampl
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-10       Impact factor: 2.915

2.  [Lymphadenectomy of the inguinal region and pelvis].

Authors:  P M Vogt; L-W Lahoda; M Meyer-Marcotty; M Spies; K H Busch
Journal:  Chirurg       Date:  2007-03       Impact factor: 0.955

Review 3.  Vulvar cancer: epidemiology, clinical presentation, and management options.

Authors:  Ibrahim Alkatout; Melanie Schubert; Nele Garbrecht; Marion Tina Weigel; Walter Jonat; Christoph Mundhenke; Veronika Günther
Journal:  Int J Womens Health       Date:  2015-03-20

4.  Interstitial high-dose-rate brachytherapy in locally advanced and recurrent vulvar cancer.

Authors:  Sylwia Kellas-Ślęczka; Brygida Białas; Marek Fijałkowski; Piotr Wojcieszek; Marta Szlag; Agnieszka Cholewka; Maciej Ślęczka; Zofia Kołosza
Journal:  J Contemp Brachytherapy       Date:  2016-02-29

Review 5.  Management of Clitoral Melanoma Presenting as an Exophytic Clitoral Mass: A Case Report and Review of the Literature.

Authors:  Alec Szlachta-McGinn; Bartosz Chmielowski; Yuna Kang; Steven Raman; Sanaz Memarzadeh
Journal:  Curr Oncol       Date:  2021-10-21       Impact factor: 3.677

6.  An evaluation of prognostic factors, oncologic outcomes, and management for primary and recurrent squamous cell carcinoma of the vulva.

Authors:  Jessie Y Li; Christopher K Arkfeld; Joan Tymon-Rosario; Emily Webster; Peter Schwartz; Shari Damast; Gulden Menderes
Journal:  J Gynecol Oncol       Date:  2021-11-30       Impact factor: 4.756

7.  Necrotizing fasciitis arising from squamous cell carcinoma of the vulva.

Authors:  Dua Cebeci; Şirin Yaşar; Tevfik Eker; Görgün Bayraktaroğlu
Journal:  Dermatol Reports       Date:  2022-03-17

8.  Prognostic factors and a value of 2009 FIGO staging system in vulvar cancer.

Authors:  Jacek J Sznurkowski; Tomasz Milczek; Janusz Emerich
Journal:  Arch Gynecol Obstet       Date:  2012-12-22       Impact factor: 2.344

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.